Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

SHE:002603 Revenue

Shijiazhuang Yiling Pharmaceutical had revenue of 1.89B CNY in the quarter ending September 30, 2026, with 3.62% growth. This brings the company's total for the last twelve months to 7.93B, up 31.86% year-over-year. In the year 2025, Shijiazhuang Yiling Pharmaceutical had annual revenue of 7.83B with 20.24% growth. That makes Shijiazhuang Yiling Pharmaceutical the 6,881st largest company in the world by revenue and 979th in China.

• Revenue (ttm): 7.93B
• Revenue Growth: +31.86%
• P/S Ratio: 3.26
• Revenue / Employee: 699.24K
• Employees: 11,343
• Market Cap: 25.86B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 7.53B 96.1%
• Overseas 302.37M 3.9%

Fiscal year ended Dec 31, 2025 See the full SHE:002603 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.83B	1.32B	20.24%
Dec 31, 2024	6.51B	-3.81B	-36.88%
Dec 31, 2023	10.32B	-2.21B	-17.67%
Jan 1, 2023	12.53B	2.42B	23.88%
Jan 1, 2022	10.12B	1.33B	15.19%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error